Skip to main content
OpenTrials

Clinical trial condition

Schizophrenia

Explore clinical trials studying Schizophrenia. Study availability and eligibility vary by location and protocol.

2,318 public trials 177 recruiting studies
Refine in advanced search Browse all conditions

Schizophrenia trial results

Completed

Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia

NCT06179108

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Pillar Clinical Research Bentonville, Arkansas, United States
  • Woodland Internation Research Group Little Rock, Arkansas, United States
  • Woodland Research Northwest Rogers, Arkansas, United States
  • CelExel Clinical Innovations Bellflower, California, United States
View all 25 locations
View Trial Details
Completed

Study of a Novel Antipsychotic ITI-007 in Schizophrenia

NCT01499563

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Clinical Site Little Rock, Arkansas, United States
  • Clinical Site Garden Grove, California, United States
  • Clinical Site Atlanta, Georgia, United States
  • Clinical Site Rockville, Maryland, United States
View Trial Details
Completed

A Trial to Assess the Antipsychotic Efficacy of ITI-007

NCT02282761

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Clinical Site Little Rock, Arkansas, United States
  • Clinical Site Springdale, Arkansas, United States
  • Clinical Site Escondido, California, United States
  • Clinical Site Garden Grove, California, United States
View Trial Details
Completed

A Trial to Assess the Antipsychotic Efficacy of ITI-007 Over 6 Weeks of Treatment

NCT02469155

Conditions
Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations
  • Clinical Site Little Rock, Arkansas, United States
  • Clinical Site Springdale, Arkansas, United States
  • Clinical Site Culver City, California, United States
  • Clinical Site Lemon Grove, California, United States
View Trial Details

Related conditions